IQVIA Holdings (WBO:IQVH) 3-Year Revenue Growth Rate : 11.40% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is IQVIA Holdings 3-Year Revenue Growth Rate?

IQVIA Holdings's Revenue per Share for the three months ended in Sep. 2024 was €19.06.

During the past 12 months, IQVIA Holdings's average Revenue per Share Growth Rate was 4.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of IQVIA Holdings was 12.50% per year. The lowest was 1.50% per year. And the median was 7.40% per year.

Competitive Comparison of IQVIA Holdings's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, IQVIA Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IQVIA Holdings's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's 3-Year Revenue Growth Rate falls into.

IQVIA Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

IQVIA Holdings (WBO:IQVH) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

IQVIA Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

IQVIA Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (WBO:IQVH) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

IQV:USA IQV:Mexico 0JDM:UK QTS:Germany

Address

2400 Ellis Road, Durham, NC, USA, 27703

Website

https://www.iqvia.com

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings Headlines

No Headlines